Die another day

Journal of Hepatology

Volumn 38, Issue 6, 2003, Pages 873-875

  Schoemaker, Marieke H ^a   Moshage, Han ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; GALACTOSAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MIFEPRISTONE; TUMOR NECROSIS FACTOR;

APOPTOSIS; CELL PROLIFERATION; GENE DELETION; GENE TRANSLOCATION; HEPATITIS; LIVER CELL; LIVER FAILURE; LIVER REGENERATION; LIVER RESECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0037902193     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00092-8     Document Type: Note

References (17)

1. Rothwarf DM, Karin M. The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus. Science STKE 1999;5:RE1 www.stke.org/cgi/content/full/OC_sigtrans;1999/5/rel.
2. Karin M. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene 1999;18:6867-6874.
3. Hoffmann A, Levchenko A, Scott ML. Baltimore D. The IκB-NF-κB signalling module: temporal control of selective gene activation. Science 2000;298:1241-1245.
4. Rodriguez MS, Thompson J, Hay RT, Dargemont C. Nuclear retention of IκBα protects it from signal-induced degradation and inhibits nuclear factor κB transcriptional activation. J Biol Chem 1999;274:9108-9115.
5. Johnson C, Van Antwerp C, Hope TJ. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα. EMBO J 1999;18:6682-6693.
6. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol Cell 2002;9:625-636.
7. Chen L, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-κB action is regulated by reversible acetylation. Science 2001;293:1653-1657.
8. Ashburner BP, Westerheide SD, Baldwin Jr AS. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001;21:7065-7077.
9. Leitges M, Sanz L, Martin P, Duran A, Braun U, Garcia JF, et al. Targeted disruption of the ζPKC gene results in the impairment of the NF-κB pathway. Mol Cell 2001;8:771-780.
10. Schoemaker MH, Ros JE, Homan M, Trautwein C, Liston P, Poelstra K, et al. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-κB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J Hepatol 2002;36:742-750.
11. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNFα requires transcriptional arrest. J Immunol 1994;153:1778-1788.
12. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, Brenner DA. NF-κB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998;101:802-811.
13. Kuhnel F, Zender L, Paul Y, Tietze MK, Trautwein C, Manns M, Kubicka S. NF-κB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem 2000;275:6421-6427.
14. Chaisson ML, Brooling JT, Ladiges W, Tsai S, Fausto N. Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 2002;110:193-202.
15. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.
16. Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM. Antibodies to TNFα inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992;263:G579-G585.
17. Loffreda S, Rai R, Yang SQ, Lin HZ, Diehl AM. Bile ducts and portal and central veins are major producers of TNFα in regenerating rat liver. Gastroenterology 1997;112:2089-2098.